Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junichi Kaburaki

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 1, 2008
[Clinical features and treatments of antiphospholipid syndrome]Junichi Kaburaki
Modern Rheumatology|July 11, 2009
Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosisMasataka Kuwana, Yuka Okazaki, Junichi Kaburaki
Rinsho Byori. the Japanese Journal of Clinical Pathology|August 20, 2003
[Antiphospholipid antibodies]Junichi Kaburaki, Masataka Kuwana, Yasuo Ikeda
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 26, 2003
[Clinical significance of anti-phosphatidylserine-prothrombin complex antibodies in the diagnosis of anti-phospholipid syndrome]Junichi Kaburaki, Masataka Kuwana, Yasuo Ikeda
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpuraMasataka Kuwana, Yuka Okazaki, Junichi Kaburaki, et al.
Blood|August 30, 2007
Excessive exposure to anionic surfaces maintains autoantibody response to beta(2)-glycoprotein I in patients with antiphospholipid syndromeYukie Yamaguchi, Noriyuki Seta, Junichi Kaburaki, et al.
Rheumatology (Oxford, England)|June 22, 2012
Heparin-dependent and -independent anti-platelet factor 4 autoantibodies in patients with systemic lupus erythematosusTakashi Satoh, Yoko Tanaka, Yuka Okazaki, et al.
Clinical Nuclear Medicine|January 24, 2007
Hypermetabolic change as a possible predictive sign of a relapsed central nervous system lymphomaTadaki Nakahara, Yaeko Takagi, Hayao Shiga, et al.
Arthritis and Rheumatism|May 27, 2006
Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosisMasataka Kuwana, Junichi Kaburaki, Yuka Okazaki, et al.
The Journal of Rheumatology|December 17, 2003
HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivitiesMasataka Kuwana, Janardan P Pandey, Richard M Silver, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 1, 2008
[Clinical features and treatments of antiphospholipid syndrome]Junichi Kaburaki
Modern Rheumatology|July 11, 2009
Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosisMasataka Kuwana, Yuka Okazaki, Junichi Kaburaki
Rinsho Byori. the Japanese Journal of Clinical Pathology|August 20, 2003
[Antiphospholipid antibodies]Junichi Kaburaki, Masataka Kuwana, Yasuo Ikeda
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 26, 2003
[Clinical significance of anti-phosphatidylserine-prothrombin complex antibodies in the diagnosis of anti-phospholipid syndrome]Junichi Kaburaki, Masataka Kuwana, Yasuo Ikeda
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpuraMasataka Kuwana, Yuka Okazaki, Junichi Kaburaki, et al.
Blood|August 30, 2007
Excessive exposure to anionic surfaces maintains autoantibody response to beta(2)-glycoprotein I in patients with antiphospholipid syndromeYukie Yamaguchi, Noriyuki Seta, Junichi Kaburaki, et al.
Rheumatology (Oxford, England)|June 22, 2012
Heparin-dependent and -independent anti-platelet factor 4 autoantibodies in patients with systemic lupus erythematosusTakashi Satoh, Yoko Tanaka, Yuka Okazaki, et al.
Clinical Nuclear Medicine|January 24, 2007
Hypermetabolic change as a possible predictive sign of a relapsed central nervous system lymphomaTadaki Nakahara, Yaeko Takagi, Hayao Shiga, et al.
Arthritis and Rheumatism|May 27, 2006
Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosisMasataka Kuwana, Junichi Kaburaki, Yuka Okazaki, et al.
The Journal of Rheumatology|December 17, 2003
HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivitiesMasataka Kuwana, Janardan P Pandey, Richard M Silver, et al.
Pageof 2